Hepatic‐Portal Vein Infusions of Glucagon‐Like Peptide‐1 Reduce Meal Size and Increase c‐Fos Expression in the Nucleus Tractus Solitarii, Area Postrema and Central Nucleus of the Amygdala in Rats

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of neuroendocrinology

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2826.2010.01995.xPMID 20298455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

  2009cited by this paper
• Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.

  2009cited by this paper
• The effects of GLP-1 infusion in the hepatic portal region on food intake.

  2009cited by this paper
• Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.

  2009cited by this paper
• Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI)

  2009cited by this paper
• Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors.

  2009cited by this paper
• Cholecystokinin: A Molecular Negative-Feedback Control of Eating

  2009cited by this paper
• Immune challenge and satiety-related activation of both distinct and overlapping neuronal populations in the brainstem indicate parallel pathways for viscerosensory signaling.

  2009cited by this paper
• Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis.

  2009cited by this paper
• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

  2008cited by this paper
• Diet-Derived Nutrients Modulate the Effects of Amylin on c-Fos Expression in the Area Postrema and on Food Intake

  2007cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• The physiology of glucagon-like peptide 1.

  2007cited by this paper
• Gastrointestinal satiety signals in humans--physiologic roles for GLP-1 and PYY?

  2006cited by this paper
• Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

  2005cited by this paper
• From the authors

  2005cited by this paper
• The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.

  2005cited by this paper
• A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.

  2004cited by this paper
• Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons.

  2003cited by this paper
• Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites

  2003cited by this paper
• Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

  2002cited by this paper
• University of Groningen Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats

  2002cited by this paper
• Peripheral protein immunization induces rapid activation of the CNS, as measured by c-Fos expression.

  2002cited by this paper
• The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness

  2002cited by this paper
• A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

  2001cited by this paper
• Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract.

  2001cited by this paper
• Estradiol treatment increases CCK-induced c-Fos expression in the brains of ovariectomized rats.

  2001cited by this paper
• Estradiol treatment increases feeding-induced c-Fos expression in the brains of ovariectomized rats.

  2001cited by this paper
• Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.

  2001cited by this paper
• Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor.

  2001cited by this paper
• The Role of CNS Glucagon-Like Peptide-1 (7-36) Amide Receptors in Mediating the Visceral Illness Effects of Lithium Chloride

  2000cited by this paper
• Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms.

  2000cited by this paper
• Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress.

  1999cited by this paper
• Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

  1999cited by this paper
• Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

  1999cited by this paper
• C-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats.

  1999cited by this paper
• Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

  1999cited by this paper
• A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.

  1999cited by this paper
• Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.

  1998cited by this paper
• Medullary c-Fos activation in rats after ingestion of a satiating meal.

  1998cited by this paper
• Comparison of Fos induced in rat brain by GLP-1 and amylin.

  1997cited by this paper
• Enteroglucagon.

  1997cited by this paper
• Glucagon-like peptide-1 and satiety

  1997cited by this paper
• Glucagon-like peptide-1 and satiety

  1997cited by this paper
• Enteroglucagon

  1994cited by this paper
• Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release.

  1993cited by this paper
• Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

  1988cited by this paper
• Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety.

  1986cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983cited by this paper
• A Simple Sequentially Rejective Multiple Test Procedure

  1979cited by this paper
• Missing Values , Outliers , Robust Statistics & Non-parametric Methods

  year unknowncited by this paper

• The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

  2026cites this paper
• Integration of Glucagon-like Peptide 1 Receptor Actions through the Central Amygdala.

  2025cites this paper
• Crosstalk between alcohol use disorder and obesity: two sides of the same coin?

  2025cites this paper
• Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart

  2024cites this paper
• Regulation of energy metabolism through central GIPR signaling.

  2024cites this paper
• Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem

  2023cites this paper
• Central GLP-1 Resistance Induced by Severe Traumatic Brain Injury Was Associated with Persistent Hyperglycemia in Humans

  2023cites this paper
• The Future of Neuroimaging and Gut-Brain Axis Research for Substance Use Disorders.

  2022cites this paper
• Role of the gut–brain axis in energy and glucose metabolism

  2022cites this paper
• Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake.

  2021cites this paper
• Raspberry Ketone [4-(4-Hydroxyphenyl)-2-Butanone] Differentially Effects Meal Patterns and Cardiovascular Parameters in Mice

  2020cites this paper
• Intestinal glucagon-like peptide-1 effects on food intake: physiological relevance and emerging mechanisms.

  2020cites this paper
• Understanding the interplay between food structure, intestinal bacterial fermentation and appetite control

  2020cites this paper
• Interacción entre la función reproductiva y metabólica: caracterización del papel de factores neuroendocrinos y el sensor energético, proteína quinasa activada por AMP (AMPK)

  2020cites this paper
• The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1

  2019cites this paper
• Serendipity and spontaneity - Critical components in 40 years of academia.

  2019cites this paper
• The incretin system in healthy humans: The role of GIP and GLP-1.

  2019influential citation
• Glucagon-like peptide 1 (GLP-1)

  2019influential citation
• Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications.

  2019cites this paper
• Signalling from the periphery to the brain that regulates energy homeostasis

  2018cites this paper
• Intestinal lymph as a readout of meal-induced GLP-1 release in an unrestrained rat model.

  2018cites this paper
• The role of intestinal hydrogen sulfide on GLP-1 secretion and downstream metabolism

  2017cites this paper
• Effects of different feeding levels during three short periods of gestation on gilt and litter performance, nutrient digestibility, and energy homeostasis in gilts.

  2017cites this paper
• The effect of metformin on neuronal activity in the appetite-regulating brain regions of mice fed a high-fat diet during an anorectic period.

  2016cites this paper
• Activation of Nesfatin-1-Containing Neurones in the Hypothalamus and Brainstem by Peripheral Administration of Anorectic Hormones and Suppression of Feeding via Central Nesfatin-1 in Rats.

  2016cites this paper
• The metabolic actions of neurotensin secreted from the gut

  2016cites this paper
• The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice.

  2016cites this paper
• Gut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.

  2016cites this paper
• Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.

  2015cites this paper
• Glucagon-Like Peptide 1 Interacts with Ghrelin and Leptin to Regulate Glucose Metabolism and Food Intake through Vagal Afferent

  2015cites this paper
• Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.

  2015cites this paper
• Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease.

  2015cites this paper
• Mechanisms of action of satiating gut peptides in the regulation of food intake through vagal afferent pathways

  2015cites this paper
• The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence

  2015cites this paper
• The role of glucagon‐like peptide‐1 impairment in obesity and potential therapeutic implications

  2014cites this paper
• Circulating glucagon-like peptide-1 (GLP-1) inhibits eating in male rats by acting in the hindbrain and without inducing avoidance.

  2014cites this paper
• Ability of GLP-1 to decrease food intake is dependent on nutritional status.

  2014cites this paper
• Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.

  2014cites this paper
• Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP‐1R activation

  2014cites this paper
• The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat.

  2014cites this paper
• High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.

  2014cites this paper
• Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-α Agonist Wy-14643 in High-Fat Diet Fed Rats

  2013cites this paper
• Refeeding after acute food restriction: differential reduction in preference for ethanol and ethanol-paired flavors in selectively bred rats.

  2013cites this paper
• Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice.

  2013influential citation
• The role of short chain fatty acids in appetite regulation

  2013cites this paper
• Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats[S]

  2013cites this paper
• Incretin hormones and the satiation signal

  2013cites this paper
• Possible mechanisms of circulating PYY-induced satiation in male rats.

  2013cites this paper
• Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP1R activation

  2013cites this paper
• Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala

  2013cites this paper
• Chapter 149 – GLP-1

  2013cites this paper
• The interaction of amylin with other hormones in the control of eating

  2013cites this paper
• Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4.

  2012cites this paper
• Physiological, Morphological and molecular biological studies of the effect of Glucagon-like peptide-1 and exenatide in the diabetic rat pancreas

  2012cites this paper
• Vagal Afferents Mediate Early Satiation and Prevent Flavour Avoidance Learning in Response to Intraperitoneally Infused Exendin‐4

  2012cites this paper
• Liraglutide: short‐lived effect on gastric emptying—long lasting effects on body weight

  2012cites this paper
• Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

  2011cites this paper
• GLP-1, the gut-brain, and brain-periphery axes.

  2011cites this paper
• Nutrition and L and K-enteroendocrine cells

  2011cites this paper
• Gastric bypass reduces fat intake and preference.

  2011cites this paper
• Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4.

  2011cites this paper
• Appetite and hedonism: gut hormones and the brain.

  2010cites this paper
• Molecular neuroendocrine targets for obesity therapy.

  2010cites this paper